Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4

Gene Therapy
M BouHamdanR J Pomerantz

Abstract

CXCR4 is the major co-receptor used by X4 strains of human immunodeficiency virus type I (HIV-1). In HIV-1-infected patients, the appearance of X4 strains (T cell line-tropic) correlates with disease progression. Since its discovery, the CXCR4 co-receptor has been a major target for different agents which block its function, such as stromal-derived factor 1alpha (SDF-1alpha) and the anti-CXCR4 monoclonal antibody, 12G5. In the present studies, the 12G5 hybridoma was used to construct a single-chain variable antibody fragment (SFv). Murine leukemia virus (MLV) and simian virus 40 (SV(40)) were utilized as delivery vehicles for the anti-CXCR4 SFv. Intracellular expression of the anti-CXCR4 SFv led to down-regulation of this critical co-receptor, as demonstrated by immunostaining. This effect significantly and specifically protected transduced cells from challenge with HIV-1, as measured by HIV-1 p24 antigen expression. Inhibition of HIV-1 replication was specific for X4 HIV-1 strains as demonstrated by MAGI assays. HeLa-CD4/betagal-CCR5 cells expressing the anti-CXCR4 SFv showed significant inhibition of infectivity by the X4 HIV-1 strain NL4-3, but not with the R5 HIV-1 strain Bal. Thus, this anti-HIV-1 molecular therapy has the...Continue Reading

References

Nov 1, 1991·European Journal of Immunology·M KaartinenO Mäkelä
May 14, 1993·Science·R C Mulligan
Mar 1, 1997·BioTechniques·D S StrayerO Bagasra
Oct 23, 1997·The Journal of Experimental Medicine·D ScholsE De Clercq
Oct 23, 1997·The Journal of Experimental Medicine·T MurakamiT Nagasawa
Jan 24, 1998·Nature·E A BergerR A Weiss
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·M L PennL Margolis
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·P SteinbergerC F Barbas
Aug 10, 2000·Molecular Therapy : the Journal of the American Society of Gene Therapy·J BaiR Akkina

❮ Previous
Next ❯

Citations

Feb 24, 2004·Folia Microbiologica·D Blazek, V Celer
Dec 11, 2007·Nature Biotechnology·John J RossiDonald B Kohn
Jun 1, 2004·DNA and Cell Biology·Maria Vera, Puri Fortes
Oct 21, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Pierre CordelierDavid S Strayer
Feb 13, 2002·AIDS Patient Care and STDs·Mario R Mautino, Richard A Morgan
Nov 13, 2014·Expert Opinion on Therapeutic Targets·Elena Herrera-Carrillo, Ben Berkhout
Aug 8, 2015·MAbs·Andrea L J MarschallThomas Böldicke
Sep 25, 2002·Clinics in Laboratory Medicine·Linda D Starr-Spires, Ronald G Collman
Aug 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lakshmi Narashimhan RamanaUma Maheswari Krishnan
Oct 1, 2013·Clinical & Developmental Immunology·Vinh T DangYee-Joo Tan
Jun 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S StrayerJohn A Zaia
Sep 29, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Maria VeraPuri Fortes
Aug 30, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·José Luis AbadAntonio Bernad
Feb 11, 2005·Gene Therapy·R Wolkowicz, G P Nolan
Apr 7, 2006·The Journal of Gene Medicine·Dorothee von LaerKlaus Hasselmann
Jan 29, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nobuya YoshidaTakeshi Tokuhisa
Apr 18, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Congcong ZhangAndrea L J Marschall
Jan 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·David S StrayerRoger J Pomerantz

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.